Cancer News

Darzalex® Approved for Additional Indications in Multiple Myeloma (11/29/2016)

The United States Food and Drug Administration (FDA) has approved Darzalex® (daratumumab) for the treatment of multiple myeloma among patients who have received at least one prior therapy. The new FDA indication also requires that daratumumab be used in combination with lenalidomide and dexamethasone, or in combination with bortezomib and dexamethasone. Daratumumab is already approved … Continue reading "Darzalex® Approved for Additional Indications in Multiple Myeloma"

Darzalex™ Effective in Heavily Pre-Treated Multiple Myeloma (07/07/2016)

The targeted agent Darzalex (daratumumab) produces long-lasting anti-cancer responses among patients with multiple myeloma that has stopped responding to several prior therapies. These results were recently published in the journal Blood. Multiple myeloma is a type of blood cancer that affects certain immune cells called plasma cells. Healthy plasma cells produce proteins called antibodies that … Continue reading "Darzalex™ Effective in Heavily Pre-Treated Multiple Myeloma"

Aplidin® Improves Progression-Free Survival in Multiple Myeloma (04/21/2016)

The addition of the investigative agent Aplidin® (plitidepsin) to dexamethasone appears to significantly reduce the risk of cancer progression or death compared to dexamethasone alone among patients with multiple myeloma that has progressed following prior therapies. Multiple myeloma is a type of blood cancer that affects certain immune cells called plasma cells. Healthy plasma cells … Continue reading "Aplidin® Improves Progression-Free Survival in Multiple Myeloma"

Combo Therapy of Kyprolis plus Dexamethasone Approved for Recurrent Multiple Myeloma (01/26/2016)

The United States Food and Drug Administration (FDA) recently approved a new treatment combination consisting of Kyprolis (carfilzomib) plus dexamethasone for patients with relapsed or refractory multiple myeloma. Multiple myeloma is a type of blood cancer that affects certain immune cells called plasma cells. Healthy plasma cells produce proteins called antibodies that are an important … Continue reading "Combo Therapy of Kyprolis plus Dexamethasone Approved for Recurrent Multiple Myeloma"